LIST OF TABLES
• TABLE 1
• TABLE 2
INCREASED INCIDENCE OF CHRONIC DISEASES AND RAPID GROWTH IN GERIATRIC POPULATION WILL DRIVE THE MARKET GROWTH.................................................................... 40
UNFAVORABLE REIMBURSEMENT AND RISING HEALTHCARE COSTS TO RESTRAIN MARKET GROWTH........................................................................................................................... 41
• TABLE 3 CONDITION SPECIFIC MARKERS, AN AREA OF OPPORTUNITY....................................................................... 41
• TABLE 4 STRINGENT & UNCERTAIN REGULATIONS, A KEY CHALLENGE FOR THE IVD MARKET................................. 42
• TABLE 5 U. S. IVD MARKET SIZE, BY PRODUCT & SERVICE, 2013 – 2020( USD MILLION)............................................. 45
• TABLE 6 U. S.: IVD MARKET SIZE, BY REGION, 2013 – 2020( USD MILLION)................................................................... 45
• TABLE 7 U. S. IVD REAGENTS MARKET SIZE, BY END USER, 2013 – 2020( USD MILLION)............................................. 46
• TABLE 8 U. S. IVD INSTRUMENTS MARKET SIZE, BY TYPE, 2013 – 2020( USD MILLION).............................................. 47
• TABLE 9 U. S. IVD INSTRUMENTS MARKET SIZE, BY END USER, 2013 – 2020( USD MILLION)...................................... 48
• TABLE 10 U. S. IVD DATA MANAGEMENT SOFTWARE MARKET SIZE, BY END USER, 2013 – 2020( USD MILLION)............................................................................................................................... 50
• TABLE 11 U. S. IVD SERVICES MARKET SIZE, BY END USER, 2013 – 2020( USD MILLION).............................................. 51
• TABLE 12 U. S. IVD MARKET SIZE, BY TECHNOLOGY, 2013 – 2020( USD MILLION).......................................................... 53
• TABLE 13 U. S. CLINICAL CHEMISTRY MARKET SIZE, BY END USER, 2013 – 2020( USD MILLION)................................ 54
• TABLE 14 U. S. IMMUNOCHEMISTRY / IMMUNOASSYS MARKET SIZE, BY END USER, 2013 – 2020( USD MILLION)............................................................................................................................... 55
• TABLE 15 U. S. MICROBIOLOGY MARKET SIZE, BY END USER, 2013 – 2020( USD MILLION)........................................... 56
• TABLE 16 U. S. MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013 – 2020( USD MILLION)............................................................................................................................... 57
• TABLE 17 U. S. HEMATOLOGY MARKET SIZE, BY END USER, 2013 – 2020( USD MILLION).............................................. 58
• TABLE 18 U. S. COAGULATION / HEMOSTASIS MARKET SIZE, BY END USER, 2013 – 2020( USD MILLION)............................................................................................................................... 59
• TABLE 19 U. S. OTHER IVD TECHNOLOGIES MARKET SIZE, BY END USER, 2013 – 2020( USD MILLION)............................................................................................................................... 60
• TABLE 20 U. S. IVD MARKET SIZE, BY APPLICATION, 2013 – 2020( USD MILLION).......................................................... 62
• TABLE 21 INFECTIOUS DISEASE INCIDENCE IN THE U. S., 2008 – 2012............................................................................ 63
• TABLE 22 HUMAN IMMUNODEFICIENCY VIRUS( HIV) PREVALENCE IN THE U. S., BY REGION...................................... 63
• TABLE 23 U. S. IVD MARKET SIZE, FOR INFECTIOUS DISEASES BY END USER, 2013 – 2020( USD MILLION)............................................................................................................................... 64
• TABLE 24 DIABETES INCIDENCE IN THE U. S., BY REGION, 2008 – 2012........................................................................... 65
• TABLE 25 U. S. IVD MARKET SIZE, FOR DIABETES BY END USER, 2013 – 2020( USD MILLION)...................................... 65
sales @ marketsandmarkets. com www. marketsandmarkets. com
17